AMA Submission to Health Technology Assessment Policy and Methods Review – Consultation 1

The AMA expects that the HTA review will ensure Australians have timely and affordable access to essential therapeutics. The submission outlines that the review process must: 

• Allow medical practitioners to feel confident in the safety, efficacy and accessibility when prescribing of medicines and therapeutic treatments for any patient 
• Provide, within reason, for industry to support Australian specialists in their use of specific therapeutics 
• Ensure that patients do not face excessive out of pocket costs for essential and lifesaving therapeutics.